Total Payments
$5,375
2024 Payments
$1,840
Companies
29
Transactions
417
Medicare Patients
922
Medicare Billing
$94,629
Payment Breakdown by Category
Food & Beverage$5,360 (99.7%)
Education$14.07 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,360 | 414 | 99.7% |
| Education | $14.07 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,106 | 107 | $0 (2024) |
| PFIZER INC. | $675.67 | 67 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $648.95 | 34 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $466.72 | 43 | $0 (2024) |
| ABBVIE INC. | $447.34 | 39 | $0 (2024) |
| Lilly USA, LLC | $393.36 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $211.35 | 13 | $0 (2024) |
| Amgen Inc. | $171.10 | 12 | $0 (2024) |
| Corium, LLC | $164.13 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $163.38 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,840 | 113 | AstraZeneca Pharmaceuticals LP ($322.41) |
| 2023 | $1,461 | 107 | Novo Nordisk Inc ($290.52) |
| 2022 | $226.67 | 11 | ABBVIE INC. ($49.73) |
| 2020 | $118.79 | 9 | PFIZER INC. ($63.48) |
| 2019 | $755.71 | 75 | Novo Nordisk Inc ($296.45) |
| 2018 | $852.12 | 93 | PFIZER INC. ($246.86) |
| 2017 | $120.00 | 9 | PFIZER INC. ($35.14) |
All Payment Transactions
417 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.62 | General |
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $1.59 | General |
| Category: Cardio-renal | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.70 | General |
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $43.57 | General |
| Category: Hematology | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: PAIN | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 258 | 386 | $72,270 | $31,621 |
| 2022 | 6 | 232 | 343 | $55,883 | $22,584 |
| 2021 | 7 | 209 | 348 | $52,440 | $23,584 |
| 2020 | 9 | 223 | 311 | $44,972 | $16,840 |
Total Patients
922
Total Services
1,388
Medicare Billing
$94,629
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 197 | $37,646 | $14,884 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 40 | $10,499 | $4,715 | 44.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $9,408 | $4,576 | 48.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $5,780 | $2,664 | 46.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $3,206 | $1,594 | 49.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 17 | $910.86 | $892.67 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $1,860 | $890.81 | 47.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $667.00 | $653.66 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $464.00 | $454.72 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 31 | $1,829 | $295.12 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 173 | $33,908 | $12,348 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 47 | $12,643 | $5,486 | 43.4% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 30 | 30 | $2,965 | $2,053 | 69.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 25 | $3,375 | $1,442 | 42.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $986.00 | $928.30 | 94.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 22 | 34 | $2,006 | $326.12 | 16.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 197 | $34,475 | $15,679 | 45.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 27 | $6,480 | $3,705 | 57.2% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 23 | 23 | $2,273 | $1,501 | 66.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $4,125 | $1,039 | 25.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $1,560 | $792.30 | 50.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 24 | 47 | $2,773 | $456.37 | 16.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 26 | 26 | $754.00 | $411.58 | 54.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 72 | 145 | $25,375 | $9,295 | 36.6% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 24 | 24 | $2,391 | $1,457 | 61.0% |
About Dr. Lisa Falotico, DO
Dr. Lisa Falotico, DO is a Sports Medicine healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1528266814.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Falotico, DO has received a total of $5,375 in payments from pharmaceutical and medical device companies, with $1,840 received in 2024. These payments were reported across 417 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,360).
As a Medicare-enrolled provider, Falotico has provided services to 922 Medicare beneficiaries, totaling 1,388 services with total Medicare billing of $94,629. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine
- Location Fort Wayne, IN
- Active Since 07/07/2007
- Last Updated 10/20/2022
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1528266814
Products in Payments
- Kerendia (Drug) $466.72
- Ozempic (Drug) $431.48
- BREZTRI (Drug) $309.70
- FARXIGA (Drug) $265.46
- VRAYLAR (Drug) $238.46
- JARDIANCE (Drug) $206.67
- CHANTIX (Drug) $199.16
- LYRICA (Drug) $169.82
- MOUNJARO (Drug) $168.60
- TRINTELLIX (Drug) $131.74
- NURTEC ODT (Drug) $129.11
- Azstarys (Drug) $115.85
- UBRELVY (Drug) $112.40
- TRELEGY ELLIPTA (Drug) $111.54
- Cologuard Collection Kit (Device) $98.77
- Victoza (Drug) $85.51
- Auvelity (Drug) $84.50
- QULIPTA (Drug) $82.15
- EUCRISA (Drug) $78.64
- ACCRUFER (Drug) $74.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Fort Wayne
Stephen Wright, Md, MD
Sports Medicine — Payments: $16,587
Sports Medicine $16,587
Jeffrey Levenda, Md, MD
Sports Medicine — Payments: $9,711
Sports Medicine $9,711
Jerald Cooper, M.d, M.D
Sports Medicine — Payments: $1,755
Sports Medicine $1,755
Matthew Snyder, Md, MD
Sports Medicine — Payments: $693.73
Sports Medicine $693.73
Gregory Sassmannshausen, M.d, M.D
Sports Medicine — Payments: $94.78
Sports Medicine $94.78
Joseph Mattox, Md, MD
Sports Medicine — Payments: $68.24
Sports Medicine $68.24